Myriad, Prometheus Pushing Life Sciences Cos. To Licensing

By Erin Coe (June 3, 2014, 4:40 PM EDT) -- The U.S. Supreme Court's decisions in Association for Molecular Pathology v. Myriad Genetics last year and Mayo v. Prometheus in 2012 found life sciences patents invalid for claiming laws of nature, rulings that lawyers say have driven life sciences companies to shift from litigation to focus directly on licensing and to try circumventing the decisions by changing how they apply for patents....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!